Exelixis Inc at Stifel Healthcare Conference Transcript
All right. So we're going to go ahead and get started. I'm Stephen Willey, one of the senior biotech analysts here at Stifel. As part of our next presentation, we have the CEO from Exelixis, Michael Morrissey. With him in attendance is Susan Hubbard, who runs up their communications effort; Chris Senner, who's their Chief Financial Officer; and Andrew Peters, who heads up their BD function.
We're just going to go right into a fireside chat. This is designed to be interactive. So if anyone has a question, feel free to [take] yourself, and hopefully, we'll get it asked.
Mike, I'm not sure if you want to make any kind of introductory comments with respect to kind of where you are, maybe what you do, and then we'll go right into Q&A.
All right. Awesome. Good morning, everybody. Before I begin, I'll just start by saying that I'll be making forward-looking statements. So please
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
